Article info

Download PDFPDF

Original research article
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high vascular risk

Authors

  • Louis Potier Département d'Endocrinologie, Diabétologie et Nutrition, DHU-FIRE, HUPNVS, AP-HP, Paris, France Université Paris Diderot-Sorbonne Paris Cité, Paris, France Centre de Recherche des Cordeliers, INSERM, U-1138, Paris, France PubMed articlesGoogle scholar articles
  • Ronan Roussel Département d'Endocrinologie, Diabétologie et Nutrition, DHU-FIRE, HUPNVS, AP-HP, Paris, France Université Paris Diderot-Sorbonne Paris Cité, Paris, France Centre de Recherche des Cordeliers, INSERM, U-1138, Paris, France PubMed articlesGoogle scholar articles
  • Yedid Elbez FACT DHU FIRE, LVTS INSERM U-1148, Hôpital Bichat, HUPNVS, AP-HP, Paris, France PubMed articlesGoogle scholar articles
  • Michel Marre Département d'Endocrinologie, Diabétologie et Nutrition, DHU-FIRE, HUPNVS, AP-HP, Paris, France Université Paris Diderot-Sorbonne Paris Cité, Paris, France Centre de Recherche des Cordeliers, INSERM, U-1138, Paris, France PubMed articlesGoogle scholar articles
  • Uwe Zeymer Klinikum Ludwigshafen und Institut für Herzinfarktforschung, Ludwigshafen, Rhineland-Palatinate, Germany PubMed articlesGoogle scholar articles
  • Christopher M Reid Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, School of Public Health, Curtin University, Centre of Cardiovascular Research and Education in Therapeutics, Melbourne, Perth, Australia PubMed articlesGoogle scholar articles
  • Magnus Ohman Division of Cardiology, Department of Medicine, Duke University Medical Center and the Duke Clinical Research Institute, Durham, North Carolina, USA PubMed articlesGoogle scholar articles
  • Kim A Eagle Department of Cardiology, University of Michigan Health System, Ann Arbor, Michigan, USA PubMed articlesGoogle scholar articles
  • Deepak L Bhatt Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Philippe Gabriel Steg Université Paris Diderot-Sorbonne Paris Cité, Paris, France FACT DHU FIRE, LVTS INSERM U-1148, Hôpital Bichat, HUPNVS, AP-HP, Paris, France NHLI Imperial College, Royal Brompton Hospital, London, UK PubMed articlesGoogle scholar articles
  • Google scholar articles
  1. Correspondence to Dr Louis Potier, Department of Diabetology, Endocrinology and Nutrition, Bichat-Claude Bernard Hospital, 46 rue Henri Huchard, Paris 75018, France; louis.potier{at}gmail.com
View Full Text

Citation

Potier L, Roussel R, Elbez Y on behalf of the REACH Registry Investigators*, et al
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high vascular risk

Publication history

  • Received September 29, 2016
  • Revised January 30, 2017
  • Accepted February 3, 2017
  • First published March 11, 2017.
Online issue publication 
August 15, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.